نتائج البحث - Rajwanshi, Richa
- يعرض 1 - 3 نتائج من 3
-
1
Population Pharmacokinetics and Exposure–Response Analyses for Venetoclax in Combination with R-CHOP in Relapsed/Refractory and Previously Untreated Patients with Diffuse Large B C... حسب Samineni, Divya, Huang, Weize, Gibiansky, Leonid, Ding, Hao, Zhang, Rong, Li, Chunze, Sinha, Arijit, Rajwanshi, Richa, Humphrey, Kathryn, Bazeos, Alexandra, Salem, Ahmed Hamed, Miles, Dale
منشور في 2021نص -
2
Pharmacokinetics and Exposure-Response Analysis of Venetoclax + Obinutuzumab in Chronic Lymphocytic Leukemia: Phase 1b Study and Phase 3 CLL14 Trial حسب Samineni, Divya, Gibiansky, Leonid, Wang, Bei, Vadhavkar, Shweta, Rajwanshi, Richa, Tandon, Maneesh, Sinha, Arijit, Al-Sawaf, Othman, Fischer, Kirsten, Hallek, Michael, Salem, Ahmed Hamed, Li, Chunze, Miles, Dale
منشور في 2022نص -
3
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti‐CD20 monoclonal antibody for the desensitization of candidates for renal transplant حسب Redfield, Robert R., Jordan, Stanley C., Busque, Stephan, Vincenti, Flavio, Woodle, E. Steve, Desai, Niraj, Reed, Elaine F., Tremblay, Simon, Zachary, Andrea A., Vo, Ashley A., Formica, Richard, Schindler, Thomas, Tran, Ha, Looney, Caroline, Jamois, Candice, Green, Cherie, Morimoto, Alyssa, Rajwanshi, Richa, Schroeder, Aaron, Cascino, Matthew D., Brunetta, Paul, Borie, Dominic
منشور في 2019نص